文献速递肝胆胰外科围术期管理与 ERAS

胰腺手术中综合并发症指数作为发病率结局指标的构建效度与信度

Construct Validity and Reliability of the Comprehensive Complication Index as a Morbidity Outcome Measure in Pancreatic Surgery.
PubMed 文献 · Ann Surg · 2025-12-17

该研究在5家意大利中心纳入797例择期胰腺手术患者,检验CCI®️的构建效度和信度。10项先验假设中9项获支持(90%),评定者间ICC=0.96(95%CI: 0.95-0.97),各中心内ICC均>0.75,SEM为2.73至6.38,支持CCI®️作为胰腺手术后发病率有效可靠的测量工具。

要点

  • CCI®️在胰腺手术中构建效度良好,9/10先验假设获确认。
  • 评定者间信度优秀(ICC=0.96,95%CI: 0.95-0.97)。
  • 各中心内信度高(ICC均>0.75),SEM为2.73至6.38。

核心结论

  • 研究支持CCI®️作为胰腺手术后发病率有效且可靠的测量工具,支持其用于临床实践和比较效果研究。

研究设计与样本

  • 基于5家意大利中心的随机对照试验(NCT04438447)和前瞻性队列研究(NCT04431076),纳入797例因任何疾病接受择期胰腺手术的患者。
  • 采用线性回归检验10项先验构建效度假设,回归系数表示组间CCI®️平均差异,效应量≥0.2视为可能有意义,>75%假设获支持则效度可接受。
  • 由6家中心中3名独立评定者对100份匿名病例摘要评估CCI®️,通过组内相关系数(ICC)和测量标准误(SEM)评价评定者间和中心间信度。

主要发现

  • 797例患者年龄66±11岁,女性占50%,恶性肿瘤占60%。
  • 构建效度获数据支持,9/10先验假设获确认(90%)。
  • CCI®️评定者间信度优秀(ICC=0.96,95%CI: 0.95-0.97),各中心内信度高(ICC均>0.75),SEM为2.73至6.38。

临床怎么用

  • 胰腺手术后可采用CCI®️量化90天累积并发症负担,支持其在临床实践和比较效果研究中的应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the reliability and construct validity of the CCI®️ following pancreatic surgery. SUMMARY BACKGROUND DATA: The Comprehensive Complication Index (CCI®️) is the only validated metric that quantifies cumulative morbidity, with a continuous score ranging from 0 (no complications) to 100 (death). METHODS: To address construct validity, we assessed patients undergoing elective pancreatic surgery for any disease at five Italian centers enrolled in a randomized controlled trial (NCT04438447) and a prospective cohort study (NCT04431076). The severity of 90-day complications was assessed using the CCI®️. We tested 10 a priori construct validity hypotheses through linear regression. Regression coefficients represented the between-group mean difference in CCI®️, with an effect size ≥0.2 considered potentially meaningful. Validity was deemed adequate if >75% of the hypotheses were supported. To address reliability, three independent raters among six centers assessed the CCI®️ from 100 anonymous case vignettes to evaluate inter-rater and inter-center reliability through intraclass correlation coefficient (ICC) and standard error of measurement (SEM). RESULTS: 797 patients were included (66±11 y, 50% female, 60% malignancy). The construct validity was supported by data, with 9/10 a priori hypotheses confirmed (90%). The CCI®️ showed excellent inter-rater (ICC=0.96, 95%CI: 0.95-0.97), high inter-center reliability (ICC >0.75 in each center), with a SEM ranging from 2.73 to 6.38. CONCLUSIONS: This study supports CCI®️as a valid and reliable measure of morbidity after pancreatic surgery, supporting its use in both clinical practice and comparative effectiveness research.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Pecorelli N, Fermi F, Abbassi F, et al. Construct Validity and Reliability of the Comprehensive Complication Index as a Morbidity Outcome Measure in Pancreatic Surgery. Ann Surg. 2025. PMID: 41403005. doi:10.1097/SLA.0000000000007002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。